Jill Durocher

TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States

May 24th, 2019
Medical Abortion
Raymond, E., Chong, E., Winikoff, B., Platais, I., Mary, M., Lotarevich, T., Castillo, P.W., Kaneshiro, B., Tschann, T., Fontanilla, T., Baldwin, M., Schnyer, A., Coplon, L., Mathieu, N., Bednarek, P., Keady, M.. Priegue, E.

Contraception; 24 May 2019; Vol. 100:173-177

Our paper demonstrating the safety, efficacy, and acceptability of our TelAbortion study has just been published in Contraception.

Some of our key findings and conclusions include:
Medical abortion can be safely and effectively provided using direct-to-patient telemedicine, which allows patients to obtain the service via videoconference and mail without an in-person visit with an abortion provider.

The TelAbortion service is highly acceptable to patients and can increase access to abortion for people who have difficulty going in person to an abortion clinic.

The U.S. Food and Drug Administration, as well as individual states, should lift legal and regulatory restrictions on abortion so that this service can be provided throughout the entire United States.